299 related articles for article (PubMed ID: 30219857)
1. Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms.
Castanheira M; Deshpande LM; Woosley LN; Serio AW; Krause KM; Flamm RK
J Antimicrob Chemother; 2018 Dec; 73(12):3346-3354. PubMed ID: 30219857
[TBL] [Abstract][Full Text] [Related]
2.
Castanheira M; Davis AP; Mendes RE; Serio AW; Krause KM; Flamm RK
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866862
[TBL] [Abstract][Full Text] [Related]
3. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance.
Galani I; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Souli M;
BMC Infect Dis; 2019 Feb; 19(1):167. PubMed ID: 30770727
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers.
Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of Plazomicin against Enterobacteriaceae isolates carrying genes encoding aminoglycoside-modifying enzymes most common in US Census divisions.
Castanheira M; Davis AP; Serio AW; Krause KM; Mendes RE
Diagn Microbiol Infect Dis; 2019 May; 94(1):73-77. PubMed ID: 30661726
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of plazomicin and older aminoglyosides against Enterobacterales isolates; prevalence of aminoglycoside modifying enzymes and 16S rRNA methyltransferases.
Gür D; Hasdemir U; Çakar A; Çavuşoğlu İ; Çelik T; Aksu B;
Diagn Microbiol Infect Dis; 2020 Aug; 97(4):115092. PubMed ID: 32569921
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
Zhang Y; Kashikar A; Bush K
J Antimicrob Chemother; 2017 Oct; 72(10):2792-2795. PubMed ID: 29091224
[TBL] [Abstract][Full Text] [Related]
8. Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates.
Denervaud-Tendon V; Poirel L; Connolly LE; Krause KM; Nordmann P
J Antimicrob Chemother; 2017 Oct; 72(10):2787-2791. PubMed ID: 29091226
[TBL] [Abstract][Full Text] [Related]
9. Activity of Plazomicin Tested against
Castanheira M; Sader HS; Mendes RE; Jones RN
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094137
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae.
Clark JA; Kulengowski B; Burgess DS
Diagn Microbiol Infect Dis; 2020 Oct; 98(2):115117. PubMed ID: 32755805
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of plazomicin against quinolone-resistant gram-negative bacteria isolated from catheter-associated urinary tract infections.
Abd-Elmonsef MME; Nagla S; Afandy ME; Maxwell SY
J Chemother; 2021 Nov; 33(7):462-468. PubMed ID: 33810779
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of plazomicin against 5,015 gram-negative and gram-positive clinical isolates obtained from patients in canadian hospitals as part of the CANWARD study, 2011-2012.
Walkty A; Adam H; Baxter M; Denisuik A; Lagacé-Wiens P; Karlowsky JA; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2014 May; 58(5):2554-63. PubMed ID: 24550325
[TBL] [Abstract][Full Text] [Related]
14. Expected plazomicin susceptibility in India based on the prevailing aminoglycoside resistance mechanisms in Gram-negative organisms derived from whole-genome sequencing.
Pragasam AK; Jennifer SL; Solaimalai D; Muthuirulandi Sethuvel DP; Rachel T; Elangovan D; Vasudevan K; Gunasekaran K; Veeraraghavan B
Indian J Med Microbiol; 2020; 38(3 & 4):313-318. PubMed ID: 33154241
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016).
Pfaller MA; Huband MD; Streit JM; Flamm RK; Sader HS
Int J Antimicrob Agents; 2018 Jun; 51(6):848-853. PubMed ID: 29410368
[TBL] [Abstract][Full Text] [Related]
16. Distribution of genes encoding 16S rRNA methyltransferase in plazomicin-nonsusceptible carbapenemase-producing Enterobacterales in Brazil.
Bail L; Ito CAS; Arend LNVS; Pilonetto M; Nogueira KDS; Tuon FF
Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115239. PubMed ID: 33130509
[TBL] [Abstract][Full Text] [Related]
17. Activity of plazomicin in combination with other antibiotics against multidrug-resistant Enterobacteriaceae.
Thwaites M; Hall D; Stoneburner A; Shinabarger D; Serio AW; Krause KM; Marra A; Pillar C
Diagn Microbiol Infect Dis; 2018 Dec; 92(4):338-345. PubMed ID: 30097297
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Activity of Plazomicin Against Carbapenem Resistant Klebsiella pneumoniae Strains.
Demirbas Z; Ozger HS; Suzuk-Yildiz S; Bakkaloglu Z; Dizbay M
Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704736
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents.
López Díaz MC; Ríos E; Rodríguez-Avial I; Simaluiza RJ; Picazo JJ; Culebras E
Int J Antimicrob Agents; 2017 Aug; 50(2):191-196. PubMed ID: 28577932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
